IBD Clinical Advisors

Home » IBD Clinical Advisors

Qu Biologics is very pleased to have engaged the following experts in gastroenterology to provide guidance and oversight of its IBD clinical trials:

Dr. Brian Feagan has been recognized as one of the top experts worldwide in inflammatory bowel diseases. In addition to serving as a Professor of Medicine at the Schulich School of Medicine & Dentistry, and as a gastroenterologist at London Health Sciences Centre, Dr. Feagan serves as Director of Clinical Trials at Robarts Research Institute.  His research interests focus on the design and implementation of randomized controlled trials of therapy for inflammatory bowel disease, and he has been the principal investigator on numerous multi-centre trials evaluating new treatments for the disease.  Recently, Feagan has also begun to investigate the application of cluster randomization in the evaluation of health policies.  This methodology is well-suited to the assessment of the effectiveness of treatment programs, such as a care path for disease management.

Dr. William Sandborn is an internationally recognized expert in the conduct of clinical trials in inflammatory bowel disease. Currently, Dr. Sandborn is a Professor of Medicine at the University of California San Diego and Director of the IBD Center and Chief of the Division of Gastroenterology for the UC San Diego Health System. He directs a large research unit where his supervises a multi-investigator team specializing in inflammatory bowel disease clinical trials.

Dr. Sandborn has published over 447 peer reviewed articles including articles in the New England Journal of Medicine, the Lancet, JAMA, the Annals of Internal Medicine, and Gastroenterology. His research interests are clinical trials and clinical pharmacology related to inflammatory bowel disease. Dr. Sandborn completed a gastroenterology fellowship at the Mayo Clinic, where he also held positions of Professor of Medicine, Vice Chairman of the Division of Gastroenterology and Hepatology, and Associate Dean of Research for Intellectual Property and Industry Relations. He completed medical school and an internal medicine residency at Loma Linda University in Loma Linda California.

Dr. Bressler is a Clinical Assistant Professor of Medicine, in the Division of Gastroenterology at the University of British Columbia’s Department of Medicine.  Dr. Bressler received his MD from the University of British Columbia and completed his residency in internal medicine and gastroenterology at the University of Toronto. He received an MS in Epidemiology from the Harvard Public School of Health and completed an advanced fellowship in Inflammatory Bowel Disease at Massachusetts General Hospital, Harvard Medical School.

Dr. Bressler is a recognized expert in inflammatory bowel disease. His research interests include population based studies, classic clinical epidemiology studies and clinical trials in inflammatory bowel disease. He is an invited reviewer for many medical journals including Gastroenterology, Clinical Gastroenterology and Hepatology, and American Journal of Gastroenterology. Dr. Bressler is a member of Qu Biologics’ Scientific Advisory Board.

Dr. Marshall is a Professor of Medicine and Director of the Division of Gastroenterology at McMaster University, as well as a consultant gastroenterologist at Hamilton Health Sciences in Hamilton Ontario. He completed his B.A. and M.D. at Queen’s University, and then undertook his residency training and M.Sc. in Clinical Epidemiology & Biostatistics at McMaster University. He is a Full Member of the Farncombe Family Digestive Health Research Institute. His publications include over 200 academic papers and book chapters and over 200 abstracts.

Dr. Marshall is the Editor-in-Chief of the Journal of the Canadian Association of Gastroenterology (JCAG). He is also an Associate Editor of ACP Journal Club and Evidence-Based Medicine, an Editorial Board Member for the Journal of Crohn’s and Colitis, and an Editor for the Cochrane Collaboration Inflammatory Bowel Disease and Functional Bowel Disorders Review Group. Past honours include the Canadian Association of Gastroenterology (CAG) Young Investigator Award (2008), the CAG Young Educator Award (2006) and Fellowship in the American Gastroenterological Association (2007). Dr. Marshall’s clinical and research interests include inflammatory bowel disease, post-infectious irritable bowel syndrome, gastrointestinal bleeding, endoscopy, clinical trials, clinical epidemiology, health outcomes and health economics.